Citation: G. Sturfelt et al., INCREASED FREQUENCY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST ALLELE IL1RN-ASTERISK-2 IN AN EPIDEMIOLOGICALLY DEFINED SYSTEMIC LUPUS-ERYTHEMATOSUS COHORT - A POSSIBLE MARKER OF KIDNEY INVOLVEMENT, Arthritis and rheumatism, 40(9), 1997, pp. 901-901
Authors:
GLADMAN DD
UROWITZ MB
GOLDSMITH CH
FORTIN P
GINZLER E
GORDON C
HANLY JG
ISENBERG DA
KALUNIAN K
NIVED O
PETRI M
SANCHEZGUERRERO J
SNAITH M
STURFELT G
Citation: Dd. Gladman et al., THE RELIABILITY OF THE SYSTEMIC LUPUS-INTERNATIONAL-COLLABORATING-CLINICS AMERICAN-COLLEGE-OF-RHEUMATOLOGY DAMAGE INDEX IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 40(5), 1997, pp. 809-813
Authors:
GLADMAN D
UROWITZ M
FORTIN P
ISENBERG D
GOLDSMITH C
GORDON C
PETRI M
BACON P
GINZLER E
HANLY JG
KALUNIAN K
LIANG M
MADDISON P
NIVED O
SANCHEZGUERRERO J
STOLL T
STURFELT G
TUCKER L
ZOMA A
Citation: D. Gladman et al., SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS CONFERENCE ON ASSESSMENT OF LUPUS FLARE AND QUALITY-OF-LIFE MEASURES IN SLE, Journal of rheumatology, 23(11), 1996, pp. 1953-1955
Authors:
HALLENGREN C
BENGTSSON A
NIVED O
STURFELT O
Citation: C. Hallengren et al., SLE IN SOUTHERN SWEDEN DURING 1981-1991 - A PROSPECTIVE EPIDEMIOLOGIC-STUDY WITH VALIDATION OF THE ARA CLASSIFICATION CRITERIA, Arthritis and rheumatism, 39(9), 1996, pp. 1648-1648
Authors:
GLADMAN D
GINZLER E
GOLDSMITH C
FORTIN P
LIANG M
UROWITZ M
BACON P
BOMBARDIERI S
HANLY J
HAY E
ISENBERG D
JONES J
KALUNIAN K
MADDISON P
NIVED O
PETRI M
RICHTER M
SANCHEZGUERRERO J
SNAITH M
STURFELT G
SYMMONS D
ZOMA A
Citation: D. Gladman et al., THE DEVELOPMENT AND INITIAL VALIDATION OF THE SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS AMERICAN-COLLEGE-OF-RHEUMATOLOGY DAMAGE INDEX FOR SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 39(3), 1996, pp. 363-369
Authors:
BENGTSSON A
BLOMBERG J
NIVED O
PIPKORN R
TOTH L
STURFELT G
Citation: A. Bengtsson et al., SELECTIVE ANTIBODY REACTIVITY WITH PEPTIDES FROM HUMAN ENDOGENOUS RETROVIRUSES AND NONVIRAL POLY(AMINO ACIDS) IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS, Arthritis and rheumatism, 39(10), 1996, pp. 1654-1663
Authors:
STURFELT G
LENHOFF S
SALLERFORS B
NIVED O
TRUEDSSON L
SJOHOLM AG
Citation: G. Sturfelt et al., TRANSPLANTATION WITH ALLOGENIC BONE-MARROW FROM A DONOR WITH SYSTEMICLUPUS-ERYTHEMATOSUS (SLE) - SUCCESSFUL OUTCOME IN THE RECIPIENT AND INDUCTION OF AN SLE FLARE IN THE DONOR, Annals of the Rheumatic Diseases, 55(9), 1996, pp. 638-641
Authors:
TRUEDSSON L
STURFELT G
JOHANSEN P
NIVED O
THURESSON B
Citation: L. Truedsson et al., SHARING OF MHC HAPLOTYPES AMONG PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS FROM UNRELATED CAUCASIAN MULTICASE FAMILIES - DISEASE ASSOCIATION WITH THE EXTENDED HAPLOTYPE [HLA-B8,SC01,DR17], Journal of rheumatology, 22(10), 1995, pp. 1852-1861
Authors:
GLADMAN D
GOLDSMITH C
UROWITZ M
BACON P
FORTIN P
GINZLER E
GORDON C
HANLY J
HAY E
ISENBERG D
KALUNIAN K
LIANG M
MADDISON P
PETRI M
NIVED O
SNAITH M
STURFELT G
SYMMONS D
Citation: D. Gladman et al., THE SLICC ACR DAMAGE INDEX FOR SLE INTERNATIONAL COMPARISON/, Arthritis and rheumatism, 38(9), 1995, pp. 132-132
Citation: L. Truedsson et al., DIFFERENT DISTRIBUTION OF TNFA MICROSATELLITES IN SLE PATIENTS COMPARED TO THE NORMAL POPULATION, Arthritis and rheumatism, 38(9), 1995, pp. 342-342
Authors:
UROWITZ M
GLADMAN D
GOLDSMITH C
FORTIN P
GINZLER E
GORDON C
HANLY J
ISENBERG D
KALUNIAN K
NIVED O
PETRI M
SANCHEZGUERRERO J
SNAITH M
STURFELT G
Citation: M. Urowitz et al., ASSESSMENT OF THE RELIABILITY OF SLICC ACR DAMAGE INDEX FOR SLE/, Arthritis and rheumatism, 38(6), 1995, pp. 37-37
Authors:
JOHNSON AE
CAVALCANTI FS
GORDON C
NIVED O
PALMER RG
STURFELT G
VINER NJ
BACON PA
Citation: Ae. Johnson et al., CROSS-SECTIONAL ANALYSIS OF THE DIFFERENCES BETWEEN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS IN ENGLAND, BRAZIL AND SWEDEN, Lupus, 3(6), 1994, pp. 501-506
Authors:
GLADMAN DD
GOLDSMITH CH
UROWITZ MB
BACON P
BOMBARDIER C
ISENBERG D
KALUNIAN K
LIANG MH
MADDISON P
NIVED O
RICHTER M
SNAITH M
SYMMONS D
ZOMA A
Citation: Dd. Gladman et al., SENSITIVITY TO CHANGE OF 3 SYSTEMIC LUPUS-ERYTHEMATOSUS DISEASE-ACTIVITY INDEXES - INTERNATIONAL VALIDATION, Journal of rheumatology, 21(8), 1994, pp. 1468-1471
Citation: O. Nived et al., A COMPARISON OF 6 MONTHS COMPLIANCE OF PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED WITH TENOXICAM AND NAPROXEN - USE OF PATIENT COMPUTER-DATA TO ASSESS RESPONSE TO TREATMENT, Journal of rheumatology, 21(8), 1994, pp. 1537-1541
Authors:
NIVED O
STURFELT G
NILSSON B
TERMANDER B
GUNNARSSON PO
STRANDGARDEN K
WOLLHEIM F
Citation: O. Nived et al., CLINICAL PILOT-STUDY OF ROQUINIMEX (LINOMIDE(R)) IN PATIENTS WITH AUTOIMMUNE-DISEASE, International journal of immunotherapy, 10(2), 1994, pp. 49-59
Authors:
BLOMBERG J
NIVED O
PIPKORN R
BENGTSSON A
ERLINGE D
STURFELT G
Citation: J. Blomberg et al., INCREASED ANTIRETROVIRAL ANTIBODY REACTIVITY IN SERA FROM A DEFINED POPULATION OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - CORRELATION WITH AUTOANTIBODIES AND CLINICAL MANIFESTATIONS, Arthritis and rheumatism, 37(1), 1994, pp. 57-66
Citation: R. Saxena et al., SIGNIFICANCE OF ANTI-ENTACTIN ANTIBODIES IN PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS AND RELATED DISORDERS, Annals of the Rheumatic Diseases, 53(10), 1994, pp. 659-665
Citation: L. Truedsson et al., PREVALENCE OF THE TYPE-I COMPLEMENT C2 DEFICIENCY GENE IN SWEDISH SYSTEMIC LUPUS-ERYTHEMATOSUS PATIENTS, Lupus, 2(5), 1993, pp. 325-327